Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3926
InterContinental Hotels
IHG
$23.6B
| $109K | ﹤0.01% |
+819
| New | +$113K |
2026 Q1
0 quarters
|
|
3927
Petco
WOOF
$630M
| $109K | ﹤0.01% |
39,141
-334,713
| -90% | -$926K |
2022 Q1
16 quarters
|
|
3928
Embecta
EMBC
$328M
| $109K | ﹤0.01% |
12,279
-92,877
| -88% | -$968K |
2022 Q2
15 quarters
|
|
3929
PUT
Arcus Biosciences
RCUS
$3.21B
| $108K | ﹤0.01% |
5,000
| – | – |
2025 Q4
1 quarter
|
|
|
CBNA
3930
Chain Bridge Bancorp
CBNA
$308M
| $108K | ﹤0.01% |
3,092
-3,211
| -51% | -$112K |
2025 Q2
3 quarters
|
|
3931
TaskUs
TASK
$757M
| $108K | ﹤0.01% |
16,052
| – | – |
2023 Q2
11 quarters
|
|
|
LIFE
3932
Ethos Technologies Inc
LIFE
$2.08B
| $107K | ﹤0.01% |
+9,609
| New | +$114K |
2026 Q1
0 quarters
|
|
3933
ACNB Corp
ACNB
$640M
| $107K | ﹤0.01% |
2,240
-13,822
| -86% | -$682K |
2022 Q2
15 quarters
|
|
3934
Consolidated Water Co
CWCO
$461M
| $107K | ﹤0.01% |
3,236
-20,295
| -86% | -$728K |
2022 Q3
14 quarters
|
|
3935
Stevanato
STVN
$5.46B
| $107K | ﹤0.01% |
+7,779
| New | +$129K |
2026 Q1
0 quarters
|
|
|
RDNW
3936
RideNow Group
RDNW
$207M
| $107K | ﹤0.01% |
15,132
-1,835
| -11% | -$11.1K |
2025 Q4
1 quarter
|
|
3937
Forafric Global
AFRI
$297M
| $106K | ﹤0.01% |
11,025
-7,000
| -39% | -$69.6K |
2023 Q2
11 quarters
|
|
|
VOXR
3938
Vox Royalty Corp
VOXR
$348M
| $106K | ﹤0.01% |
20,296
-81,720
| -80% | -$437K |
2025 Q2
3 quarters
|
|
3939
CVR Partners
UAN
$1.32B
| $106K | ﹤0.01% |
839
+814
| +3,256% | +$93.1K |
2025 Q3
2 quarters
|
|
3940
Cytek Biosciences
CTKB
$755M
| $106K | ﹤0.01% |
24,143
-159,096
| -87% | -$751K |
2022 Q1
16 quarters
|
|
3941
FTAI Infrastructure
FIP
$307M
| $105K | ﹤0.01% |
21,326
-155,028
| -88% | -$868K |
2023 Q1
12 quarters
|
|
3942
Arcturus Therapeutics
ARCT
$375M
| $105K | ﹤0.01% |
13,630
-36,959
| -73% | -$270K |
2019 Q3
26 quarters
|
|
3943
Westrock Coffee
WEST
$781M
| $105K | ﹤0.01% |
24,755
-37,783
| -60% | -$169K |
2023 Q2
11 quarters
|
|
3944
Community Health Systems
CYH
$388M
| $105K | ﹤0.01% |
35,774
-164,019
| -82% | -$531K |
2013 Q2
51 quarters
|
|
3945
Ohio Valley Banc Corp
OVBC
$209M
| $105K | ﹤0.01% |
2,383
-4,981
| -68% | -$208K |
2025 Q2
3 quarters
|
|
|
ALX
3946
Alexander's
ALX
$1.25B
| $104K | ﹤0.01% |
442
-2,912
| -87% | -$694K |
2013 Q2
51 quarters
|
|
|
GOCO
3947
DELISTED
GoHealth
GOCO
| $104K | ﹤0.01% |
68,923
-12,258
| -15% | -$23.4K |
2022 Q1
16 quarters
|
|
3948
AllianzIM U.S. Equity Buffer10 Jun ETF
JUNT
$118M
| $104K | ﹤0.01% |
2,881
-1,132
| -28% | -$41.3K |
2025 Q1
4 quarters
|
|
|
OKUR
3949
OnKure Therapeutics
OKUR
$103M
| $104K | ﹤0.01% |
25,000
-2,242
| -8% | -$6.92K |
2022 Q1
16 quarters
|
|
|
HVII
3950
DELISTED
Hennessy Capital Investment Corp VII
HVII
| $104K | ﹤0.01% |
10,000
| – | – |
2025 Q4
1 quarter
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.